The DOI matches its Crossref record; 237 of the 237 references it cites were found in a registry or an index.
The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment
Open accessAbstract
Primary aldosteronism is characterized by aldosterone secretion that is independent of renin and angiotensin II and sodium status. The deleterious effects of primary aldosteronism are mediated by excessive activation of the mineralocorticoid receptor that results in the well-known consequences of volume expansion, hypertension, hypokalemia, and metabolic alkalosis, but it also increases the risk for cardiovascular and kidney disease, as well as death. For decades, the approaches to defining, diagnosing, and treating primary aldosteronism have been relatively constant and generally focused on detecting and treating the more severe presentations of the disease. However, emerging evidence suggests that the prevalence of primary aldosteronism is much greater than previously recognized, and that milder and nonclassical forms of renin-independent aldosterone secretion that impart heightened cardiovascular risk may be common. Public health efforts to prevent aldosterone-mediated end-organ disease will require improved capabilities to diagnose all forms of primary aldosteronism while optimizing the treatment approaches such that the excess risk for cardiovascular and kidney disease is adequately mitigated. In this review, we present a physiologic approach to considering the diagnosis, pathogenesis, and treatment of primary aldosteronism. We review evidence suggesting that primary aldosteronism manifests across a wide spectrum of severity, ranging from mild to overt, that correlates with cardiovascular risk. Furthermore, we review emerging evidence from genetic studies that begin to provide a theoretical explanation for the pathogenesis of primary aldosteronism and a link to its phenotypic severity spectrum and prevalence. Finally, we review human studies that provide insights into the optimal approach toward the treatment of primary aldosteronism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Mills, K. T., Bundy, J. D., Kelly, T. N., Reed, J. E., Kearney, P. M., Reynolds, K., Chen, J., & He, J. (2016) · Circulation · doi:10.1161/circulationaha.115.018912 · Cited by 3,531
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4061 · Cited by 2,925
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X., Plouin, P.-F., Blacher, J., Safar, M. E., & Mourad, J.-J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,547
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Williams, B., MacDonald, T. M., Morant, S., Webb, D. J., Sever, P., McInnes, G., Ford, I., Cruickshank, J. K., Caulfield, M. J., Salsbury, J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00257-3 · Cited by 1,308
Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
Monticone, S., D'Ascenzo, F., Moretti, C., Williams, T. A., Veglio, F., Gaita, F., & Mulatero, P. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30319-4 · Cited by 1,072
Self-citationK + Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
Choi, M., Scholl, U. I., Yue, P., Björklund, P., Zhao, B., Nelson-Williams, C., Ji, W., Cho, Y., Patel, A., Men, C. J., et al. (2011) · Science · doi:10.1126/science.1198785 · Cited by 1,004
Williams, T. A., Lenders, J. W. M., Mulatero, P., Burrello, J., Rottenkolber, M., Adolf, C., Satoh, F., Amar, L., Quinkler, M., Deinum, J., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30135-3 · Cited by 969
Self-citationPresidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome.
Conn, J. W. (1955) · PubMed · Cited by 955
Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice
Monticone, S., Burrello, J., Tizzani, D., Bertello, C., Viola, A., Buffolo, F., Gabetti, L., Mengozzi, G., Williams, T. A., Rabbia, F., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.052 · Cited by 882
Self-citationHyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763
Brook, R. D., & Rajagopalan, S. (2018) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2018.01.004 · Cited by 728
Primary aldosteronism: renaissance of a syndrome
Young, W. F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02775.x · Cited by 680
Hundemer, G. L., Curhan, G. C., Yozamp, N., Wang, M., & Vaidya, A. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30367-4 · Cited by 677
Self-citationScholl, U. I., Goh, G., Stölting, G., de Oliveira, R. C., Choi, M., Overton, J. D., Fonseca, A. L., Korah, R., Starker, L. F., Kunstman, J. W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2695 · Cited by 627
Rossi, G. P., Auchus, R. J., Brown, M., Lenders, J. W. M., Naruse, M., Plouin, P. F., Satoh, F., & Young, W. F. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02097 · Cited by 613
Beuschlein, F., Boulkroun, S., Osswald, A., Wieland, T., Nielsen, H. N., Lichtenauer, U. D., Penton, D., Schack, V. R., Amar, L., Fischer, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2550 · Cited by 577
Serum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons
Vasan, R. S., Evans, J. C., Larson, M. G., Wilson, P. W. F., Meigs, J. B., Rifai, N., Benjamin, E. J., & Levy, D. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033263 · Cited by 571
Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment
Catena, C. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.33 · Cited by 565
OMURA, M., SAITO, J., YAMAGUCHI, K., KAKUTA, Y., & NISHIKAWA, T. (2004) · Hypertension Research · doi:10.1291/hypres.27.193 · Cited by 562
Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension
Azizan, E. A. B., Poulsen, H., Tuluc, P., Zhou, J., Clausen, M. V., Lieb, A., Maniero, C., Garg, S., Bochukova, E. G., Zhao, W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2716 · Cited by 544
Oliver, W. J., Cohen, E. L., & Neel, J. V. (1975) · Circulation · doi:10.1161/01.cir.52.1.146 · Cited by 539
Regulation of Potassium Homeostasis
Palmer, B. F. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08580813 · Cited by 535
Savard, S., Amar, L., Plouin, P.-F., & Steichen, O. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01060 · Cited by 505
Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
Brilla, C. G., & Weber, K. T. (1992) · PubMed · Cited by 505
Primary Aldosteronism and Hypertensive Disease
Mosso, L., Carvajal, C., González, A., Barraza, A., Avila, F., Montero, J., Huete, A., Gederlini, A., & Fardella, C. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000079505.25750.11 · Cited by 488
Aldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy
Rocha, R. (2000) · Endocrinology · doi:10.1210/en.141.10.3871 · Cited by 475
Tissier, F., Cavard, C., Groussin, L., Perlemoine, K., Fumey, G., Hagneré, A.-M., René-Corail, F., Jullian, E., Gicquel, C., Bertagna, X., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0593 · Cited by 474
Renal Damage in Primary Aldosteronism: Results of the PAPY Study
Rossi, G. P., Bernini, G., Desideri, G., Fabris, B., Ferri, C., Giacchetti, G., Letizia, C., Maccario, M., Mannelli, M., Matterello, M.-J., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000230444.01215.6a · Cited by 470
On the constitutional and local effects of disease of the supra-renal capsules
Addison, T. (1855) · Medical Entomology and Zoology · Cited by 437
Long-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism
Mulatero, P., Monticone, S., Bertello, C., Viola, A., Tizzani, D., Iannaccone, A., Crudo, V., Burrello, J., Milan, A., Rabbia, F., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2805 · Cited by 415
Self-citationLong-term Renal Outcomes in Patients With Primary Aldosteronism
Sechi, L. A., Novello, M., Lapenna, R., Baroselli, S., Nadalini, E., Colussi, G. L., & Catena, C. (2006) · JAMA · doi:10.1001/jama.295.22.2638 · Cited by 388
Prevalence and Characteristics of the Metabolic Syndrome in Primary Aldosteronism
Fallo, F., Veglio, F., Bertello, C., Sonino, N., Della Mea, P., Ermani, M., Rabbia, F., Federspil, G., & Mulatero, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1733 · Cited by 372
Self-citationScholl, U. I., Stölting, G., Nelson-Williams, C., Vichot, A. A., Choi, M., Loring, E., Prasad, M. L., Goh, G., Carling, T., Juhlin, C. C., et al. (2015) · eLife · doi:10.7554/elife.06315 · Cited by 358
Catena, C., Colussi, G., Lapenna, R., Nadalini, E., Chiuch, A., Gianfagna, P., & Sechi, L. A. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.095448 · Cited by 358
Rossi, G. P., Cesari, M., Cuspidi, C., Maiolino, G., Cicala, M. V., Bisogni, V., Mantero, F., & Pessina, A. C. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01316 · Cited by 356
Hiramatsu, K. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.141.12.1589 · Cited by 355
Williams, B., MacDonald, T. M., Morant, S. V., Webb, D. J., Sever, P., McInnes, G. T., Ford, I., Cruickshank, J. K., Caulfield, M. J., Padmanabhan, S., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30071-8 · Cited by 347
Acute and chronic regulation of aldosterone production
Hattangady, N. G., Olala, L. O., Bollag, W. B., & Rainey, W. E. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.034 · Cited by 347
Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors
McCurley, A., Pires, P. W., Bender, S. B., Aronovitz, M., Zhao, M. J., Metzger, D., Chambon, P., Hill, M. A., Dorrance, A. M., Mendelsohn, M. E., et al. (2012) · Nature Medicine · doi:10.1038/nm.2891 · Cited by 347
Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands
Nishimoto, K., Tomlins, S. A., Kuick, R., Cani, A. K., Giordano, T. J., Hovelson, D. H., Liu, C.-J., Sanjanwala, A. R., Edwards, M. A., Gomez-Sanchez, C. E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505529112 · Cited by 334
Hiramatsu, K. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340130033011 · Cited by 334
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma
Fernandes-Rosa, F. L., Williams, T. A., Riester, A., Steichen, O., Beuschlein, F., Boulkroun, S., Strom, T. M., Monticone, S., Amar, L., Meatchi, T., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03419 · Cited by 310
Self-citationAdrenocortical zonation in humans under normal and pathological conditions
Nishimoto, K., Nakagawa, K., Li, D., Kosaka, T., Oya, M., Mikami, S., Shibata, H., Itoh, H., Mitani, F., Yamazaki, T., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2010 · Cited by 310
Diagnosis and Treatment of Primary Hyperaldosteronism
Blumenfeld, J. D., Sealey, J. E., Schlussel, Y., Vaughan, E. D., Sos, T. A., Atlas, S. A., Muller, F. B., Acevedo, R., Ulick, S., & Laragh, J. H. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-11-199412010-00010 · Cited by 308
A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism
Geller, D. S., Zhang, J., Wisgerhof, M. V., Shackleton, C., Kashgarian, M., & Lifton, R. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0594 · Cited by 296
Development of monoclonal antibodies against human CYP11B1 and CYP11B2
Gomez-Sanchez, C. E., Qi, X., Velarde-Miranda, C., Plonczynski, M. W., Parker, C. R., Rainey, W., Satoh, F., Maekawa, T., Nakamura, Y., Sasano, H., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.11.022 · Cited by 283
Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism
Arlt, W., Lang, K., Sitch, A. J., Dietz, A. S., Rhayem, Y., Bancos, I., Feuchtinger, A., Chortis, V., Gilligan, L. C., Ludwig, P., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93136 · Cited by 281
Resistant Hypertension, Obesity, Sleep Apnea, and Aldosterone: Theory and Therapy
Goodfriend, T. L., & Calhoun, D. A. (2004) · Hypertension · doi:10.1161/01.hyp.0000116223.97436.e5 · Cited by 279
Observational Study Mortality in Treated Primary Aldosteronism: The German Conn's Registry
Reincke, M., Fischer, E., Gerum, S., Merkle, K., Schulz, S., Pallauf, A., Quinkler, M., Hanslik, G., Lang, K., Hahner, S., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.197111 · Cited by 278
de Kloet, E. R., Meijer, O. C., de Nicola, A. F., de Rijk, R. H., & Joëls, M. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.02.003 · Cited by 278
Blood pressure in four remote populations in the INTERSALT Study.
Carvalho, J. J., Baruzzi, R. G., Howard, P. F., Poulter, N., Alpers, M. P., Franco, L. J., Marcopito, L. F., Spooner, V. J., Dyer, A. R., & Elliott, P. (1989) · Hypertension · doi:10.1161/01.hyp.14.3.238 · Cited by 275
Rossier, B. C., Baker, M. E., & Studer, R. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00011.2014 · Cited by 269
CLCN2 chloride channel mutations in familial hyperaldosteronism type II
Scholl, U. I., Stölting, G., Schewe, J., Thiel, A., Tan, H., Nelson-Williams, C., Vichot, A. A., Jin, S. C., Loring, E., Untiet, V., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0048-5 · Cited by 266
Aldosterone Excretion Among Subjects With Resistant Hypertension and Symptoms of Sleep Apnea
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., & Harding, S. M. (2004) · Chest · doi:10.1378/chest.125.1.112 · Cited by 260
Scholl, U. I., Nelson-Williams, C., Yue, P., Grekin, R., Wyatt, R. J., Dillon, M. J., Couch, R., Hammer, L. K., Harley, F. L., Farhi, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121407109 · Cited by 259
CACNA1H mutations in autism spectrum disorders
Splawski, I., Yoo, D. S., Stotz, S. C., Cherry, A., Clapham, D. E., & Keating, M. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603316200 · Cited by 255
Collecting Duct Intercalated Cell Function and Regulation
Roy, A., Al-bataineh, M. M., & Pastor-Soler, N. M. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08880914 · Cited by 252
Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism
Hundemer, G. L., Curhan, G. C., Yozamp, N., Wang, M., & Vaidya, A. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11568 · Cited by 245
Self-citationIS ALZHEIMER'S DISEASE DISTINCT FROM NORMAL AGEING?
HOFMAN, A. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92339-2 · Cited by 240
Hundemer, G. L., Curhan, G. C., Yozamp, N., Wang, M., & Vaidya, A. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.2003 · Cited by 240
Self-citationBerthon, A., Sahut-Barnola, I., Lambert-Langlais, S., de Joussineau, C., Damon-Soubeyrand, C., Louiset, E., Taketo, M. M., Tissier, F., Bertherat, J., Lefrançois-Martinez, A.-M., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq029 · Cited by 239
Štrauch, B., Zelinka, T., Hampf, M., Bernhardt, R., & Widimsky, J. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001554 · Cited by 237
Wnt-4 Deficiency Alters Mouse Adrenal Cortex Function, Reducing Aldosterone Production
Heikkilä, M., Peltoketo, H., Leppäluoto, J., Ilves, M., Vuolteenaho, O., & Vainio, S. (2002) · Endocrinology · doi:10.1210/en.2002-220275 · Cited by 234
Rossi, G. P., Bolognesi, M., Rizzoni, D., Seccia, T. M., Piva, A., Porteri, E., Tiberio, G. A. M., Giulini, S. M., Agabiti-Rosei, E., & Pessina, A. C. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.111369 · Cited by 232
The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study
Brown, J. M., Robinson-Cohen, C., Luque-Fernandez, M. A., Allison, M. A., Baudrand, R., Ix, J. H., Kestenbaum, B., de Boer, I. H., & Vaidya, A. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0882 · Cited by 221
Self-citationNewton-Cheh, C., Guo, C.-Y., Gona, P., Larson, M. G., Benjamin, E. J., Wang, T. J., Kathiresan, S., O’Donnell, C. J., Musone, S. L., Camargo, A. L., et al. (2007) · Hypertension · doi:10.1161/01.hyp.0000258554.87444.91 · Cited by 218
A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism
Fernandes-Rosa, F. L., Daniil, G., Orozco, I. J., Göppner, C., El Zein, R., Jain, V., Boulkroun, S., Jeunemaitre, X., Amar, L., Lefebvre, H., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0053-8 · Cited by 215
Lenzini, L., Rossitto, G., Maiolino, G., Letizia, C., Funder, J. W., & Rossi, G. P. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2149 · Cited by 214
Lafferty, A. R., Torpy, D. J., Stowasser, M., Taymans, S. E., Lin, J. P., Huggard, P., Gordon, R. D., & Stratakis, C. A. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.11.831 · Cited by 212
Body Mass Index Predicts Aldosterone Production in Normotensive Adults on a High-Salt Diet
Bentley-Lewis, R., Adler, G. K., Perlstein, T., Seely, E. W., Hopkins, P. N., Williams, G. H., & Garg, R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1088 · Cited by 212
Self-citationCellular and Genetic Causes of Idiopathic Hyperaldosteronism
Omata, K., Satoh, F., Morimoto, R., Ito, S., Yamazaki, Y., Nakamura, Y., Anand, S. K., Guo, Z., Stowasser, M., Sasano, H., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11086 · Cited by 209
Montori, V. M., & Young, W. F. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(02)00013-0 · Cited by 202
Continuum of Renin-Independent Aldosteronism in Normotension
Baudrand, R., Guarda, F. J., Fardella, C., Hundemer, G., Brown, J., Williams, G., & Vaidya, A. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08952 · Cited by 202
Self-citationMCKENNA, T. J., SEQUEIRA, S. J., HEFFERNAN, A., CHAMBERS, J., & CUNNINGHAM, S. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-952 · Cited by 200
Comparison of Confirmatory Tests for the Diagnosis of Primary Aldosteronism
Mulatero, P., Milan, A., Fallo, F., Regolisti, G., Pizzolo, F., Fardella, C., Mosso, L., Marafetti, L., Veglio, F., & Maccario, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0078 · Cited by 195
Self-citationSuppressed Plasma Renin Activity in Essential Hypertension
JOSE, A., Crout, J. R., & Kaplan, N. M. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-1-9 · Cited by 194
Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term
Rossi, G. P., Maiolino, G., Flego, A., Belfiore, A., Bernini, G., Fabris, B., Ferri, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10596 · Cited by 194
Factors Affecting the Aldosterone/Renin Ratio
Stowasser, M., Ahmed, A., Pimenta, E., Taylor, P., & Gordon, R. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0031-1295460 · Cited by 192
A review of the medical treatment of primary aldosteronism
Lim, P. O., Young, W. F., & MacDonald, T. M. (2001) · Journal of Hypertension · doi:10.1097/00004872-200103000-00001 · Cited by 191
Worldwide prevalence of hypertension exceeds 1.3 billion
Bloch, M. J. (2016) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2016.08.006 · Cited by 191
Age-Related Autonomous Aldosteronism
Nanba, K., Vaidya, A., Williams, G. H., Zheng, I., Else, T., & Rainey, W. E. (2017) · Circulation · doi:10.1161/circulationaha.117.028201 · Cited by 191
Self-citationShibata, S., Rinehart, J., Zhang, J., Moeckel, G., Castañeda-Bueno, M., Stiegler, A. L., Boggon, T. J., Gamba, G., & Lifton, R. P. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.005 · Cited by 188
Åkerström, T., Crona, J., Delgado Verdugo, A., Starker, L. F., Cupisti, K., Willenberg, H. S., Knoefel, W. T., Saeger, W., Feller, A., Ip, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041926 · Cited by 188
Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans
Nanba, K., Omata, K., Else, T., Beck, P. C. C., Nanba, A. T., Turcu, A. F., Miller, B. S., Giordano, T. J., Tomlins, S. A., & Rainey, W. E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01004 · Cited by 181
CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels
Pinggera, A., Lieb, A., Benedetti, B., Lampert, M., Monteleone, S., Liedl, K. R., Tuluc, P., & Striessnig, J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.020 · Cited by 180
Factors Influencing Outcome of Surgery for Primary Aldosteronism
Celen, O. (1996) · Archives of Surgery · doi:10.1001/archsurg.1996.01430180072015 · Cited by 179
Activating mutations in CTNNB1 in aldosterone producing adenomas
Åkerström, T., Maharjan, R., Sven Willenberg, H., Cupisti, K., Ip, J., Moser, A., Stålberg, P., Robinson, B., Alexander Iwen, K., Dralle, H., et al. (2016) · Scientific Reports · doi:10.1038/srep19546 · Cited by 178
Expression and Mutations of KCNJ5 mRNA in Japanese Patients with Aldosterone-Producing Adenomas
Taguchi, R., Yamada, M., Nakajima, Y., Satoh, T., Hashimoto, K., Shibusawa, N., Ozawa, A., Okada, S., Rokutanda, N., Takata, D., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2885 · Cited by 178
Potassium Channel Mutant KCNJ5 T158A Expression in HAC-15 Cells Increases Aldosterone Synthesis
Oki, K., Plonczynski, M. W., Luis Lam, M., Gomez-Sanchez, E. P., & Gomez-Sanchez, C. E. (2012) · Endocrinology · doi:10.1210/en.2011-1733 · Cited by 176
Risk Factors Associated with a Low Glomerular Filtration Rate in Primary Aldosteronism
Reincke, M., Rump, L. C., Quinkler, M., Hahner, S., Diederich, S., Lorenz, R., Seufert, J., Schirpenbach, C., Beuschlein, F., Bidlingmaier, M., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1851 · Cited by 175
Carey, R. M. (1972) · Archives of Internal Medicine · doi:10.1001/archinte.130.6.849 · Cited by 173
Mulatero, P., Tizzani, D., Viola, A., Bertello, C., Monticone, S., Mengozzi, G., Schiavone, D., Williams, T. A., Einaudi, S., Grotta, A. L., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.175083 · Cited by 172
Self-citationEstimated 24-Hour Urinary Sodium and Potassium Excretion in US Adults
Cogswell, M. E., Loria, C. M., Terry, A. L., Zhao, L., Wang, C.-Y., Chen, T.-C., Wright, J. D., Pfeiffer, C. M., Merritt, R., Moy, C. S., et al. (2018) · JAMA · doi:10.1001/jama.2018.1156 · Cited by 172
Conn, J. W. (1964) · PubMed · Cited by 171
CACNA1H Mutations Are Associated With Different Forms of Primary Aldosteronism
Daniil, G., Fernandes-Rosa, F. L., Chemin, J., Blesneac, I., Beltrand, J., Polak, M., Jeunemaitre, X., Boulkroun, S., Amar, L., Strom, T. M., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.10.002 · Cited by 171
Kang, S., Cooper, G., Dunne, S. F., Dusel, B., Luan, C.-H., Surmeier, D. J., & Silverman, R. B. (2012) · Nature Communications · doi:10.1038/ncomms2149 · Cited by 169
Pregnancy, Primary Aldosteronism, and AdrenalCTNNB1Mutations
Teo, A. E. D., Garg, S., Shaikh, L. H., Zhou, J., Karet, F. E., Gurnell, M., Happerfield, L. C., Marker, A. J., Bienz, M., Azizan, E. A. B. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504869 · Cited by 168
Somatic ATP1A1 , ATP2B3 , and KCNJ5 Mutations in Aldosterone-Producing Adenomas
Williams, T. A., Monticone, S., Schack, V. R., Stindl, J., Burrello, J., Buffolo, F., Annaratone, L., Castellano, I., Beuschlein, F., Reincke, M., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.01733 · Cited by 167
Self-citationGenotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas
Williams, T. A., Peitzsch, M., Dietz, A. S., Dekkers, T., Bidlingmaier, M., Riester, A., Treitl, M., Rhayem, Y., Beuschlein, F., Lenders, J. W. M., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06186 · Cited by 167
Scholl, U. I., Healy, J. M., Thiel, A., Fonseca, A. L., Brown, T. C., Kunstman, J. W., Horne, M. J., Dietrich, D., Riemer, J. C., Kücükköylü, S., et al. (2015) · Clinical Endocrinology · doi:10.1111/cen.12873 · Cited by 166
Sukor, N., Kogovsek, C., Gordon, R. D., Robson, D., & Stowasser, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1763 · Cited by 165
Rossi, E. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02969-2 · Cited by 164
Smith, C. G., & Vane, J. R. (2003) · The FASEB Journal · doi:10.1096/fj.03-0093life · Cited by 161
Role of Rac1–mineralocorticoid-receptor signalling in renal and cardiac disease
Nagase, M., & Fujita, T. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.282 · Cited by 159
Stowasser, M., & Gordon, R. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00026.2015 · Cited by 159
Aldosterone and Mineralocorticoid Receptors—Physiology and Pathophysiology
Funder, J. W. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051032 · Cited by 158
Hanslik, G., Wallaschofski, H., Dietz, A., Riester, A., Reincke, M., Allolio, B., Lang, K., Quack, I., Rump, L. C., Willenberg, H. S., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0450 · Cited by 155
Adrenal Cortex Remodeling and Functional Zona Glomerulosa Hyperplasia in Primary Aldosteronism
Boulkroun, S., Samson-Couterie, B., Dzib, J. F. G., Lefèbvre, H., Louiset, E., Amar, L., Plouin, P., Lalli, E., Jeunemaître, X., Benecke, A., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.158543 · Cited by 155
Omata, K., Anand, S. K., Hovelson, D. H., Liu, C., Yamazaki, Y., Nakamura, Y., Ito, S., Satoh, F., Sasano, H., Rainey, W. E., et al. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00134 · Cited by 154
Suppressed Plasma Renin Activity in Hypertension
Channick, B. J. (1969) · Archives of Internal Medicine · doi:10.1001/archinte.1969.00300120019003 · Cited by 152
Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma
Zheng, F.-F., Zhu, L.-M., Nie, A.-F., Li, X.-Y., Lin, J.-R., Zhang, K., Chen, J., Zhou, W.-L., Shen, Z.-J., Zhu, Y.-C., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.03346 · Cited by 151
50th Anniversary of Aldosterone
Williams, J. S., & Williams, G. H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030490 · Cited by 150
Aldosterone Paradox: Differential Regulation of Ion Transport in Distal Nephron
Arroyo, J. P., Ronzaud, C., Lagnaz, D., Staub, O., & Gamba, G. (2011) · Physiology · doi:10.1152/physiol.00049.2010 · Cited by 149
Long term outcome of Aldosteronism after target treatments
Wu, V., Wang, S., Chang, C., Hu, Y., Lin, L., Lin, Y., Chueh, S., Chen, L., & Wu, K. (2016) · Scientific Reports · doi:10.1038/srep32103 · Cited by 149
Screening for Endocrine Hypertension: An Endocrine Society Scientific Statement
Young, W. F., Calhoun, D. A., Lenders, J. W. M., Stowasser, M., & Textor, S. C. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00054 · Cited by 144
Velema, M. S., Dekkers, T., Hermus, A. R., Timmers, H. J. L. M., Lenders, J. W. M., Groenewoud, H., Kool, L. J. S., Langenhuijsen, J. F., Prejbisz, A., van der Wilt, G. J., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01442 · Cited by 142
SECRETION OF A SALT-RETAINING HORMONE BY THE MAMMALIAN ADRENAL CORTEX
SIMPSON, S. A., Tait, J. F., & Bush, I. E. (1952) · The Lancet · doi:10.1016/s0140-6736(52)91551-1 · Cited by 136
Cardiac Damage Prevention by Eplerenone: Comparison With Low Sodium Diet or Potassium Loading
Martinez-Vasquez, D., Rocha, R., Matsumura, M., Oestreicher, E. M., Ochoa-Maya, M. R., Roubsanthisuk, W., Williams, G. H., & Adler, G. K. (2002) · Hypertension · doi:10.1161/hyp.39.2.614 · Cited by 134
Self-citationSatoh, F., Morimoto, R., Ono, Y., Iwakura, Y., Omata, K., Kudo, M., Takase, K., Seiji, K., Sasamoto, H., Honma, S., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04453 · Cited by 134
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism
Williams, T. A., Burrello, J., Sechi, L. A., Fardella, C., Matrozova, J., Adolf, C., Baudrand, R. F., Bernardi, S., Beuschlein, F., Catena, C., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11382 · Cited by 134
Self-citationBonnet, S., Gaujoux, S., Launay, P., Baudry, C., Chokri, I., Ragazzon, B., Libé, R., René-Corail, F., Audebourg, A., Vacher-Lavenu, M.-C., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1885 · Cited by 133
Takeda, R., Matsubara, T., Miyamori, I., Hatakeyama, H., & Morise, T. (1995) · Journal of Endocrinological Investigation · doi:10.1007/bf03347840 · Cited by 132
Laredo, J., Shah, J. R., Zhuo-Ren, L. U., Hamilton, B. P., & Hamlyn, J. M. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.401 · Cited by 128
Proye, C. A. G., Mulliez, E., Carnaille, B. M. L., Lecomte-Houcke, M., Decoulx, M., Wemeau, J. L., Lefèbvre, J., Racadot, A., Ernst, O., Huglo, D. G., et al. (1998) · Surgery · doi:10.1067/msy.1998.93108 · Cited by 125
Plasma Renin Activity in Primary Aldosteronism
Conn, J. W. (1964) · JAMA · doi:10.1001/jama.1964.03070160046009 · Cited by 123
Role of ACTH and Other Hormones in the Regulation of Aldosterone Production in Primary Aldosteronism
Ghorayeb, N. E., Bourdeau, I., & Lacroix, A. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00072 · Cited by 122
The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes
Wu, V., Wang, S., Chueh, S., Yang, S., Huang, K., Lin, Y., Wang, J., Connolly, R., Hu, Y., Gómez-Sánchez, C. E., et al. (2017) · Scientific Reports · doi:10.1038/srep39121 · Cited by 121
Kalogeropoulos, A. P., Georgiopoulou, V. V., Murphy, R. A., Newman, A. B., Bauer, D. C., Harris, T. B., Yang, Z., Applegate, W. B., & Kritchevsky, S. B. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.6278 · Cited by 116
Nakamura, Y., Maekawa, T., Felizola, S. J. A., Satoh, F., Qi, X., Velarde‐Miranda, C., Plonczynski, M. W., Ise, K., Kikuchi, K., Rainey, W. E., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.05.002 · Cited by 115
Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia
Williams, J. S., Williams, G. H., Raji, A., Jeunemaı̂tre, X., Brown, N. J., Hopkins, P. N., & Conlin, P. R. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001948 · Cited by 115
Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis
Tesch, G. H., & Young, M. J. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00313 · Cited by 115
Hannemann, A., Bidlingmaier, M., Friedrich, N., Manolopoulou, J., Spyroglou, A., Völzke, H., Beuschlein, F., Seißler, J., Rettig, R., Felix, S. B., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1013 · Cited by 114
Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years
Wu, V., Chueh, S., Chen, L., Chang, C., Hu, Y., Lin, Y., Wu, K., & Yang, W. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001361 · Cited by 113
Markou, A., Pappa, T., Kaltsas, G., Gouli, A., Mitsakis, K., Tsounas, P., Prevoli, A., Tsiavos, V., Papanastasiou, L., Zografos, G., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3353 · Cited by 112
Pinggera, A., Mackenroth, L., Rump, A., Schallner, J., Beleggia, F., Wollnik, B., & Striessnig, J. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx175 · Cited by 112
Long‐term Follow‐up after Adrenalectomy for Primary Aldosteronism
Meyer, A. A., Brabant, G. E., & Behrend, M. (2005) · World Journal of Surgery · doi:10.1007/s00268-004-7496-z · Cited by 110
Reproducibility of urinary biomarkers in multiple 24-h urine samples
Sun, Bertrand, K. A., Franke, A. A., ROSNER, B. A., Curhan, G. C., & Willett, W. C. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.139758 · Cited by 110
Genetic Causes of Functional Adrenocortical Adenomas
Zennaro, M., Boulkroun, S., & Fernandes-Rosa, F. L. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00189 · Cited by 109
Markou, Α., Sertedaki, A., Kaltsas, G., Androulakis, I. I., Marakaki, C., Παππά, Θ., Gouli, A., Papanastasiou, L., Fountoulakis, S., Zacharoulis, A., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1268 · Cited by 107
Lo, C. Y., Tam, P. C., Kung, A. W. C., Lam, K. S. L., & Wong, J. (1996) · Annals of Surgery · doi:10.1097/00000658-199608000-00003 · Cited by 106
Wu, V., Huang, K., Peng, K., Tsai, Y., Wu, C., Wang, S., Yang, S., Lin, L., Chang, C., Lin, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep11396 · Cited by 104
Isolation of a Highly Active Mineralocorticoid from Beef Adrenal Extract
Grundy, H. M., SIMPSON, S. A., & Tait, J. F. (1952) · Nature · doi:10.1038/169795a0 · Cited by 103
Baker, M. E., & Katsu, Y. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0661 · Cited by 103
Bone involvement in aldosteronism
Salcuni, A. S., Palmieri, S., Carnevale, V., Morelli, V., Battista, C., Guarnieri, V., Guglielmi, G., Desina, G., Eller-Vainicher, C., Beck-Peccoz, P., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1660 · Cited by 101
Mueller, K. B., Bender, S. B., Hong, K., Yang, Y., Aronovitz, M. A., Jaisser, F., Hill, M. A., & Jaffe, I. Z. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06172 · Cited by 99
Kitamoto, T., Suematsu, S., Matsuzawa, Y., Saito, J., Omura, M., & Nishikawa, T. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.24455 · Cited by 96
Bramlage, P., Swift, S. L., Thoenes, M., Minguet, J., Ferrero, C., & Schmieder, R. E. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.444 · Cited by 92
Normal and Altered Function of the Renin-Angiotensin-Aldosterone System in Man
Conn, J. W., ROVNER, D. R., & COHEN, E. L. (1965) · Annals of Internal Medicine · doi:10.7326/0003-4819-63-2-266 · Cited by 90
Bone health and aldosterone excess
Ceccoli, L., Ronconi, V., Giovannini, L., Marcheggiani, M., Turchi, F., Boscaro, M., & Giacchetti, G. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2399-1 · Cited by 88
Risk of Fracture in Primary Aldosteronism: A Population-Based Cohort Study
Wu, V., Chang, C., Wang, C.-Y., Lin, Y., Kao, T., Lin, P., Chu, T., Chang, Y.-S., Chen, L., Wu, K., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3033 · Cited by 88
Mechanisms by which a CACNA1H mutation in epilepsy patients increases seizure susceptibility
Eckle, V., Shcheglovitov, A., Vitko, I., Dey, D., Yap, C. C., Winckler, B., & Perez‐Reyes, E. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.264176 · Cited by 86
Scholl, U. I., Abriola, L., Zhang, C., Reimer, E. N., Plummer, M. S., Kazmierczak, B. I., Zhang, J., Hoyer, D., Merkel, J. S., Wang, W., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91733 · Cited by 86
Smooth Muscle Cell–Mineralocorticoid Receptor as a Mediator of Cardiovascular Stiffness With Aging
Kim, S. K., McCurley, A., DuPont, J. J., Aronovitz, M. A., Moss, M. E., Stillman, I. E., Karumanchi, S. A., Christou, D. D., & Jaffe, I. Z. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10437 · Cited by 85
Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis
Gómez-Sánchez, E. P. (2014) · Steroids · doi:10.1016/j.steroids.2014.08.014 · Cited by 84
Fourkiotis, V., Vonend, O., Diederich, S., Fischer, E., Lang, K., Endres, S., Beuschlein, F., Willenberg, H. S., Rump, L. C., Allolio, B., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0631 · Cited by 84
Dietary Sodium Restriction Increases the Risk of Misinterpreting Mild Cases of Primary Aldosteronism
Baudrand, R. F., Guarda, F. J., Torrey, J., Williams, G. H., & Vaidya, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1963 · Cited by 80
Self-citationNakamura, Y., Satoh, F., Morimoto, R., Kudo, M., Takase, K., Gómez-Sánchez, C. E., Honma, S., Okuyama, M., Yamashita, K., Rainey, W. E., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2785 · Cited by 78
Aging and Adrenal Aldosterone Production
Nanba, K., Vaidya, A., & Rainey, W. E. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.10391 · Cited by 77
Self-citationDiagnostic approach to low‐renin hypertension
Monticone, S., Losano, I., Tetti, M., Buffolo, F., Veglio, F., & Mulatero, P. (2018) · Clinical Endocrinology · doi:10.1111/cen.13741 · Cited by 74
Self-citationMarzano, L. A., Colussi, G., Sechi, L. A., & Catena, C. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu154 · Cited by 73
Primary aldosteronism: learning from the study of familial varieties
Stowasser, M., & Gordon, R. D. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018090-00002 · Cited by 72
Wang, B., Li, X., Zhang, X., Ma, X., Chen, L., Zhang, Y., Lyu, X., Tang, Y., Huang, Q., Gao, Y., et al. (2015) · Medicine · doi:10.1097/md.0000000000000708 · Cited by 72
Cortisol dysregulation in obesity-related metabolic disorders
Baudrand, R. F., & Vaidya, A. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000152 · Cited by 72
Self-citationPathogenesis of Adrenal Aldosterone-Producing Adenomas Carrying Mutations of the Na+/K+-ATPase
Stindl, J., Tauber, P., Sterner, C. W., Tegtmeier, I., Warth, R., & Bandulik, S. (2015) · Endocrinology · doi:10.1210/en.2015-1466 · Cited by 71
ACTH-induced hypertension is dependent on the ouabain-binding site of the α2-Na+-K+-ATPase subunit
Lorenz, J. N., Loreaux, E. L., Dostanic‐Larson, I., Lasko, V. M., Schnetzer, J. R., Paul, R. J., & Lingrel, J. B. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00183.2008 · Cited by 70
Kitamoto, T., Suematsu, S., Yamazaki, Y., Nakamura, Y., Sasano, H., Matsuzawa, Y., Saito, J., Omura, M., & Nishikawa, T. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3284 · Cited by 70
Jin, Y., Kuznetsova, T., Maillard, M. P., Richart, T., Thijs, L., Bochud, M., Herregods, M., Burnier, M., Fagard, R., & Staessen, J. A. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.130492 · Cited by 69
Qi, Y., Wang, X., Rose, K. L., McDonald, W. H., Zhang, B., Schey, K. L., & Luther, J. M. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014111137 · Cited by 69
Hundemer, G. L., Baudrand, R. F., Brown, J. M., Curhan, G. C., Williams, G. H., & Vaidya, A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3867 · Cited by 69
Self-citationThe Low-Renin Hypertension Phenotype: Genetics and the Role of the Mineralocorticoid Receptor
Baudrand, R. F., & Vaidya, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020546 · Cited by 68
Self-citationWolley, M. J., Wu, A., Xu, S., Gordon, R. D., Fenton, R. A., & Stowasser, M. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015111221 · Cited by 67
Aldosterone responses to hyperkalemia in healthy elderly humans.
Mulkerrin, E. C., Epstein, F. H., & Clark, B. A. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v651459 · Cited by 66
Murata, M., Kitamura, T., Tamada, D., Mukai, K., Kurebayashi, S., Yamamoto, T., Hashimoto, K., Hayashi, R., Kouhara, H., Takeiri, S., et al. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001251 · Cited by 65
Aldosterone-Producing Cell Clusters in Normal and Pathological States
Omata, K., Tomlins, S. A., & Rainey, W. E. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-122394 · Cited by 65
Obesity and episodic memory function
Loprinzi, P. D., & Frith, E. (2018) · The Journal of Physiological Sciences · doi:10.1007/s12576-018-0612-x · Cited by 65
Integration of transcriptome and methylome analysis of aldosterone-producing adenomas
Murakami, M., Yoshimoto, T., Nakabayashi, K., Tsuchiya, K., Minami, I., Bouchi, R., Izumiyama, H., Fujii, Y., Abe, K., Tayama, C., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0148 · Cited by 64
Review of surgical management of aldosterone secreting tumours of the adrenal cortex
Harris, D. A., Au-Yong, I., Basnyat, P. S., Sadler, G. P., & Wheeler, M. H. (2003) · European Journal of Surgical Oncology · doi:10.1016/s0748-7983(03)00051-9 · Cited by 63
Developmental plasticity and disparity in early dipnoan (lungfish) dentitions
Ahlberg, P., Smith, M. M., & Johanson, Z. (2006) · Evolution & Development · doi:10.1111/j.1525-142x.2006.00106.x · Cited by 63
ENDOCRINE TUMOURS: The genomics of adrenocortical tumors
Faillot, S., & Assié, G. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1118 · Cited by 62
Aldosterone Dysregulation With Aging Predicts Renal Vascular Function and Cardiovascular Risk
Brown, J. M., UNDERWOOD, P. C., Ferri, C., Hopkins, P. N., Williams, G. H., Adler, G. K., & Vaidya, A. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03231 · Cited by 59
Self-citationGENETICS IN ENDOCRINOLOGY: The expanding genetic horizon of primary aldosteronism
Monticone, S., Buffolo, F., Tetti, M., Veglio, F., Pasini, B., & Mulatero, P. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0946 · Cited by 59
Self-citationAbnormal Aldosterone Physiology and Cardiometabolic Risk Factors
Vaidya, A., UNDERWOOD, P. C., Hopkins, P. N., Jeunemaı̂tre, X., Ferri, C., Williams, G. H., & Adler, G. K. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00662 · Cited by 58
Self-citationOno, Y., Nakamura, Y., Maekawa, T., Felizola, S. J. A., Morimoto, R., Iwakura, Y., Kudo, M., Seiji, K., Takase, K., Arai, Y., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02944 · Cited by 58
An Update on Familial Hyperaldosteronism
Korah, H. E., & Scholl, U. I. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1564166 · Cited by 57
Regulation of aldosterone secretion by Cav1.3
Xie, C. B., Shaikh, L. H., Garg, S., Tanriver, G., Teo, A. E. D., Zhou, J., Maniero, C., Zhao, W., Kang, S., Silverman, R. B., et al. (2016) · Scientific Reports · doi:10.1038/srep24697 · Cited by 55
Human Adrenocortical Remodeling Leading to Aldosterone-Producing Cell Cluster Generation
Nishimoto, K., Seki, T., Hayashi, Y., Mikami, S., Al‐Eyd, G., Nakagawa, K., Morita, S., Kosaka, T., Oya, M., Mitani, F., et al. (2016) · International Journal of Endocrinology · doi:10.1155/2016/7834356 · Cited by 55
Chen, W., Li, F., He, C., Zhu, Y., & Tan, W. (2014) · Irish Journal of Medical Science · doi:10.1007/s11845-013-1007-x · Cited by 53
Baron, S., Amar, L., Faucon, A., Blanchard, A., Baffalie, L., Faucard, C., Travers, S. A. A., Pagny, J.-Y., Azizi, M., & Houillier, P. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001735 · Cited by 53
Stowasser, M., Klemm, S. A., Tunny, T. J., Storie, W. J., Rutherford, J. C., & Gordon, R. D. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02520.x · Cited by 52
Howard, B., Wang, Y., Xekouki, P., Faucz, F. R., Jain, M., Zhang, L., Meltzer, P. G., Stratakis, C. A., & Kebebew, E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3495 · Cited by 52
Health-Related Quality of Life and Mental Health in Primary Aldosteronism: A Systematic Review
Velema, M. S., de Nooijer, A., Burgers, V. W. G., Hermus, A. R., Timmers, H. J. L. M., Lenders, J. W. M., Husson, O., & Deinum, J. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-121706 · Cited by 52
Adrenal Histopathology in Primary Aldosteronism: Is It Time for a Change?
Gioco, F., Seccia, T. M., Gómez-Sánchez, E. P., Rossi, G. P., & Gómez-Sánchez, C. E. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05873 · Cited by 51
Mineralocorticoid Receptors: Evolutionary and Pathophysiological Considerations
Kassahn, K. S., Ragan, M. A., & Funder, J. W. (2011) · Endocrinology · doi:10.1210/en.2010-1444 · Cited by 51
Rossi, G. P., Cesari, M., Letizia, C., Seccia, T. M., Cicala, M. V., Zinnamosca, L., Kuppusamy, M., Mareso, S., Sciomer, S., Iacobone, M., et al. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000186 · Cited by 51
Hasegawa, T., Masugi, F., Ogihara, T., et al. (1987) · PubMed · Cited by 50
Cited by
The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study
Brown, J. M., Siddiqui, M., Calhoun, D. A., Carey, R. M., Hopkins, P. N., Williams, G. H., & Vaidya, A. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0065 · Cited by 649
Self-citationPrimary Aldosteronism: An Endocrine Society Clinical Practice Guideline
Adler, G. K., Stowasser, M., Correa, R. R., Khan, N., Kline, G., McGowan, M. J., Mulatero, P., Murad, M. H., Touyz, R. M., Vaidya, A., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf284 · Cited by 355
Self-citationMulatero, P., Monticone, S., Deinum, J., Amar, L., Prejbisz, A., Zennaro, M.-C., Beuschlein, F., Rossi, G. P., Nishikawa, T., Morganti, A., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002510 · Cited by 317
Self-citationPrimary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment
Hundemer, G. L. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1185-x · Cited by 27
Metadata
- Authors
- Vaidya, A., Mulatero, P., Baudrand, R., & Adler, G. K.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2018-08-15
- Volume
- 39
- Issue
- 6
- Pages
- 1057-1088
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2887931962
- Cited by
- 299
- References
- 237
- FWCI
- 14.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.